Cetera Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-3,611
Closed -$398K 742
2016
Q3
$398K Buy
3,611
+24
+0.7% +$2.76K 0.03% 481
2016
Q2
$439K Sell
3,587
-595
-14% -$71.8K 0.03% 446
2016
Q1
$465K Buy
+4,182
New +$434K 0.04% 417
2015
Q4
Sell
-2,856
Closed -$284K 723
2015
Q3
$284K Buy
2,856
+103
+4% +$11.2K 0.03% 511
2015
Q2
$310K Buy
+2,753
New +$334K 0.03% 510

Other funds holding CLB

Cetera Advisors's CLB Position: Q4 2016 in Review

Cetera Advisors sold out of Core Laboratories (CLB) in Q4 2016, closing a stake of 3,611 shares — an estimated $398K sold.

Cetera Advisors first reported a position in CLB in Q2 2015 and held it in 5 quarters. The position peaked at $465K in Q1 2016. 372 funds tracked by Wall St. Rank hold CLB as of Q4 2016.

  • Cetera Advisors reported no remaining Core Laboratories position as of Q4 2016 after selling out during the quarter.
  • Cetera Advisors sold 3,611 Core Laboratories shares in Q4 2016, an estimated $398K.
  • Cetera Advisors first reported a position in Core Laboratories in Q2 2015 and held it in 5 quarters.
  • Cetera Advisors's Core Laboratories position peaked at $465K in Q1 2016.
  • 372 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2016.

Based on Cetera Advisors's 13F filing for Q4 2016, filed 15 Feb 2017.